Company profile
Theragnostics company profile
Theragnostics Ltd was founded in August 2015 to develop and commercialise diagnostic and therapeutic agents. Theragnostics Inc was established in November 2016 to provide a US presence through our office in Boston, MA. Our aim is to provide a complete portfolio of products to transform patient care, from initial diagnosis to therapy, including treatment planning and monitoring. Central to this strategy is the Galli® technology which is revolutionizing PET Gallium-68 diagnostics and radionuclide therapy. Our most advanced product is THG-001, aka Ga-68 THP-PSMA, which is currently under clinical development. The Galli® technology and the concept of a single step gallium..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- https://theragnostics.com/
- Contact email
- [email protected]
- Phone number
- +44 (0)330 606 7437
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Founded
- 2015-01-01
Headquarters
- Headquarters
- Bracknell, England, United Kingdom
- Postal code
- RG12 1WA
- Country code
- GB
- Continent
- Europe